Thomas Reiberger
@reibergerthomas.bsky.social
Professor of Hepatology @MedUni_Wien
Director CD-Lab for #PortalHypertension & #LiverFibrosis
Adjunct PI @cemm-vienna.bsky.social
Head #KFG #MOTION funded by @lbg.ac.at
Scientific Secretary @bavenocoop.bsky.social
Director CD-Lab for #PortalHypertension & #LiverFibrosis
Adjunct PI @cemm-vienna.bsky.social
Head #KFG #MOTION funded by @lbg.ac.at
Scientific Secretary @bavenocoop.bsky.social
Loss of Bile Salt Export Pump (Bsep/Abcb11) Ameliorates Toxin-induced Hepatic Fibrosis via Suppression of Hepatocellular Jun Amino-terminal Kinase Signaling and Hepatic Stellate Cell Activation -
Cellular and Molecular Gastroenterology and Hepatology
www.cmghjournal.org/article/S235...
Cellular and Molecular Gastroenterology and Hepatology
www.cmghjournal.org/article/S235...
Loss of Bile Salt Export Pump (Bsep/Abcb11) Ameliorates Toxin-induced Hepatic Fibrosis via Suppression of Hepatocellular Jun Amino-terminal Kinase Signaling and Hepatic Stellate Cell Activation
Loss of Bsep/Abcb11 results in a hydrophilic bile acid (BA) pool consisting of tetrahydroxylated
BAs (THBAs) reducing cholestasis-induced liver injury. In this study, we investigated
whether loss of B...
www.cmghjournal.org
October 27, 2025 at 8:29 PM
Loss of Bile Salt Export Pump (Bsep/Abcb11) Ameliorates Toxin-induced Hepatic Fibrosis via Suppression of Hepatocellular Jun Amino-terminal Kinase Signaling and Hepatic Stellate Cell Activation -
Cellular and Molecular Gastroenterology and Hepatology
www.cmghjournal.org/article/S235...
Cellular and Molecular Gastroenterology and Hepatology
www.cmghjournal.org/article/S235...
#Liver #Cirrhosis #PortalHypertension
A recent @meduniwien.ac.at study investigated #cirrhosis pts with variceal bleeding over two 🕐 🕕 🕘 decades:
✅ decreasing rebleeding🩸rates
✅ lower bleeding-related ☠️ mortality
in the more recent decade ☺️
📕 GIE Endoscopy
🔗 www.giejournal.org/article/S001...
A recent @meduniwien.ac.at study investigated #cirrhosis pts with variceal bleeding over two 🕐 🕕 🕘 decades:
✅ decreasing rebleeding🩸rates
✅ lower bleeding-related ☠️ mortality
in the more recent decade ☺️
📕 GIE Endoscopy
🔗 www.giejournal.org/article/S001...
Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decades
Acute variceal bleeding (AVB), a severe adverse event of portal hypertension, may
cause death in patients with cirrhosis. We investigated whether outcomes after AVB
have improved over time.
www.giejournal.org
October 15, 2025 at 9:19 PM
#Liver #Cirrhosis #PortalHypertension
A recent @meduniwien.ac.at study investigated #cirrhosis pts with variceal bleeding over two 🕐 🕕 🕘 decades:
✅ decreasing rebleeding🩸rates
✅ lower bleeding-related ☠️ mortality
in the more recent decade ☺️
📕 GIE Endoscopy
🔗 www.giejournal.org/article/S001...
A recent @meduniwien.ac.at study investigated #cirrhosis pts with variceal bleeding over two 🕐 🕕 🕘 decades:
✅ decreasing rebleeding🩸rates
✅ lower bleeding-related ☠️ mortality
in the more recent decade ☺️
📕 GIE Endoscopy
🔗 www.giejournal.org/article/S001...
Pathomechanistic #Phenotypes of #Cirrhosis
Dalila Costa🇵🇹 Jonel Trebicka🇩🇪 Cristina Ripoll🇪🇸 Richard Moreau🇫🇷 @rajivjalan.bsky.social🇬🇧 Reiberger🇦🇹
📈 Portal Hypertension #PH & 🔥 Inflammation #SI coexist in pts w/ cirrhosis
💡review on PH-SI interplay in distinct cirrhosis stages
@easlnews.bsky.social
Dalila Costa🇵🇹 Jonel Trebicka🇩🇪 Cristina Ripoll🇪🇸 Richard Moreau🇫🇷 @rajivjalan.bsky.social🇬🇧 Reiberger🇦🇹
📈 Portal Hypertension #PH & 🔥 Inflammation #SI coexist in pts w/ cirrhosis
💡review on PH-SI interplay in distinct cirrhosis stages
@easlnews.bsky.social
New online! Interaction of inflammation and portal hypertension in cirrhosis progression
Interaction of inflammation and portal hypertension in cirrhosis progression
Nature Reviews Gastroenterology & Hepatology, Published online: 29 September 2025; doi:10.1038/s41575-025-01107-2Portal hypertension and systemic inflammation are key factors driving decompensation and organ failure in cirrhosis. This Review examines those two factors and, based on their mechanistic interaction, proposes a new concept of the clinical phenotypes in decompensated cirrhosis.
www.nature.com
September 30, 2025 at 7:06 AM
Pathomechanistic #Phenotypes of #Cirrhosis
Dalila Costa🇵🇹 Jonel Trebicka🇩🇪 Cristina Ripoll🇪🇸 Richard Moreau🇫🇷 @rajivjalan.bsky.social🇬🇧 Reiberger🇦🇹
📈 Portal Hypertension #PH & 🔥 Inflammation #SI coexist in pts w/ cirrhosis
💡review on PH-SI interplay in distinct cirrhosis stages
@easlnews.bsky.social
Dalila Costa🇵🇹 Jonel Trebicka🇩🇪 Cristina Ripoll🇪🇸 Richard Moreau🇫🇷 @rajivjalan.bsky.social🇬🇧 Reiberger🇦🇹
📈 Portal Hypertension #PH & 🔥 Inflammation #SI coexist in pts w/ cirrhosis
💡review on PH-SI interplay in distinct cirrhosis stages
@easlnews.bsky.social
Today these two fellows rocked their VENIA DOCENDI
🎓David CHROMY : STIs & #HepatitisC
🎓Mathias JACHS : NITs in #PortalHypertension
my personal highlights:
@mathiasjachs.bsky.social in @lancetgastrohep.bsky.social
Spleen Stiffness
🔗 t.ly/DysXB
Chromy in #UEGJ
DAAs in acute #HCV
🔗 t.ly/nIZ2a
🎓David CHROMY : STIs & #HepatitisC
🎓Mathias JACHS : NITs in #PortalHypertension
my personal highlights:
@mathiasjachs.bsky.social in @lancetgastrohep.bsky.social
Spleen Stiffness
🔗 t.ly/DysXB
Chromy in #UEGJ
DAAs in acute #HCV
🔗 t.ly/nIZ2a
September 29, 2025 at 7:57 PM
Today these two fellows rocked their VENIA DOCENDI
🎓David CHROMY : STIs & #HepatitisC
🎓Mathias JACHS : NITs in #PortalHypertension
my personal highlights:
@mathiasjachs.bsky.social in @lancetgastrohep.bsky.social
Spleen Stiffness
🔗 t.ly/DysXB
Chromy in #UEGJ
DAAs in acute #HCV
🔗 t.ly/nIZ2a
🎓David CHROMY : STIs & #HepatitisC
🎓Mathias JACHS : NITs in #PortalHypertension
my personal highlights:
@mathiasjachs.bsky.social in @lancetgastrohep.bsky.social
Spleen Stiffness
🔗 t.ly/DysXB
Chromy in #UEGJ
DAAs in acute #HCV
🔗 t.ly/nIZ2a
Our @GeorgKRAMER myself & @CristinaRIPOLL perspective on staging of #Decompensated #Cirrhosis
- this was a Letter ✉️ to @jhepatology.bsky.social in response to an article by Dr. Verma @rajivjalan.bsky.social et al
#NonAcuteDecompensation (NAD) 🔗 t.ly/mc4VG
- who responded w/ an interesting proposal
- this was a Letter ✉️ to @jhepatology.bsky.social in response to an article by Dr. Verma @rajivjalan.bsky.social et al
#NonAcuteDecompensation (NAD) 🔗 t.ly/mc4VG
- who responded w/ an interesting proposal
September 28, 2025 at 7:14 PM
Our @GeorgKRAMER myself & @CristinaRIPOLL perspective on staging of #Decompensated #Cirrhosis
- this was a Letter ✉️ to @jhepatology.bsky.social in response to an article by Dr. Verma @rajivjalan.bsky.social et al
#NonAcuteDecompensation (NAD) 🔗 t.ly/mc4VG
- who responded w/ an interesting proposal
- this was a Letter ✉️ to @jhepatology.bsky.social in response to an article by Dr. Verma @rajivjalan.bsky.social et al
#NonAcuteDecompensation (NAD) 🔗 t.ly/mc4VG
- who responded w/ an interesting proposal
❓Does #Smoking matter in #Cirrhosis❓
@benedikthofer.bsky.social
of @meduniwien.ac.at
demonstrates that indeed smoking
📈 triggers 🔥 inflammation & 🩸angiogenesis
🦀 leads to extrahepatic cancer
🦀 and tends to increase risk of #livercancer #HCC
📕 @LiverInt
🔗 t.ly/8Vr-0
@benedikthofer.bsky.social
of @meduniwien.ac.at
demonstrates that indeed smoking
📈 triggers 🔥 inflammation & 🩸angiogenesis
🦀 leads to extrahepatic cancer
🦀 and tends to increase risk of #livercancer #HCC
📕 @LiverInt
🔗 t.ly/8Vr-0
September 3, 2025 at 9:52 AM
❓Does #Smoking matter in #Cirrhosis❓
@benedikthofer.bsky.social
of @meduniwien.ac.at
demonstrates that indeed smoking
📈 triggers 🔥 inflammation & 🩸angiogenesis
🦀 leads to extrahepatic cancer
🦀 and tends to increase risk of #livercancer #HCC
📕 @LiverInt
🔗 t.ly/8Vr-0
@benedikthofer.bsky.social
of @meduniwien.ac.at
demonstrates that indeed smoking
📈 triggers 🔥 inflammation & 🩸angiogenesis
🦀 leads to extrahepatic cancer
🦀 and tends to increase risk of #livercancer #HCC
📕 @LiverInt
🔗 t.ly/8Vr-0
Transcriptome analysis shows that 67% (n=13563) of all human proteins (n=20162) are expressed in the liver and 978 of these genes show an elevated expression in the liver compared to other tissue types.
Source: www.proteinatlas.org/humanproteom...
Source: www.proteinatlas.org/humanproteom...
The human proteome in liver - The Human Protein Atlas
www.proteinatlas.org
August 30, 2025 at 2:11 AM
Transcriptome analysis shows that 67% (n=13563) of all human proteins (n=20162) are expressed in the liver and 978 of these genes show an elevated expression in the liver compared to other tissue types.
Source: www.proteinatlas.org/humanproteom...
Source: www.proteinatlas.org/humanproteom...
Reposted by Thomas Reiberger
🚨 How do ⚡injury mechanisms and 🕑 disease states from health ➡️ fibrosis ➡️ regression shape the NO–sGC–cGMP pathway in chronic #liver #cirrhosis?
Check out our comprehensive assessment of regulation patterns of this pivotal pathway here:
rdcu.be/exM9Z
@reibergerthomas.bsky.social
Check out our comprehensive assessment of regulation patterns of this pivotal pathway here:
rdcu.be/exM9Z
@reibergerthomas.bsky.social
Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis models
Scientific Reports - Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis models
rdcu.be
July 28, 2025 at 9:33 AM
🚨 How do ⚡injury mechanisms and 🕑 disease states from health ➡️ fibrosis ➡️ regression shape the NO–sGC–cGMP pathway in chronic #liver #cirrhosis?
Check out our comprehensive assessment of regulation patterns of this pivotal pathway here:
rdcu.be/exM9Z
@reibergerthomas.bsky.social
Check out our comprehensive assessment of regulation patterns of this pivotal pathway here:
rdcu.be/exM9Z
@reibergerthomas.bsky.social
🌍 #WorldHepatitisDay #2025
🇦🇹 contributions to understanding & Elimination of #Hepatitis
1⃣ #HBV-ART in #HIV 🔗 t.ly/6TXxR
2⃣ Curing #HCV in #HIV 🔗 t.ly/FiLPq
3⃣ Eliminate #HCV in 🇦🇹AT 🔗 t.ly/CBw3o
4⃣ Followup after #HCV cure 🔗 t.ly/KvSrs
🇦🇹 contributions to understanding & Elimination of #Hepatitis
1⃣ #HBV-ART in #HIV 🔗 t.ly/6TXxR
2⃣ Curing #HCV in #HIV 🔗 t.ly/FiLPq
3⃣ Eliminate #HCV in 🇦🇹AT 🔗 t.ly/CBw3o
4⃣ Followup after #HCV cure 🔗 t.ly/KvSrs
July 28, 2025 at 1:54 PM
🌍 #WorldHepatitisDay #2025
🇦🇹 contributions to understanding & Elimination of #Hepatitis
1⃣ #HBV-ART in #HIV 🔗 t.ly/6TXxR
2⃣ Curing #HCV in #HIV 🔗 t.ly/FiLPq
3⃣ Eliminate #HCV in 🇦🇹AT 🔗 t.ly/CBw3o
4⃣ Followup after #HCV cure 🔗 t.ly/KvSrs
🇦🇹 contributions to understanding & Elimination of #Hepatitis
1⃣ #HBV-ART in #HIV 🔗 t.ly/6TXxR
2⃣ Curing #HCV in #HIV 🔗 t.ly/FiLPq
3⃣ Eliminate #HCV in 🇦🇹AT 🔗 t.ly/CBw3o
4⃣ Followup after #HCV cure 🔗 t.ly/KvSrs
Reposted by Thomas Reiberger
Chronische #Lebererkrankungen im Fokus: @mathiasjachs.bsky.social, #ResearcherOfTheMonth der #MedUniWien, hat gezeigt, dass Pfortaderhochdruck schmerzfrei durch Messung der Organsteifigkeit diagnostiziert werden kann.
Mehr im Video in gesamter Länge! 🎥➡️ https://bit.ly/3G6VoGC
Mehr im Video in gesamter Länge! 🎥➡️ https://bit.ly/3G6VoGC
July 17, 2025 at 1:11 PM
Chronische #Lebererkrankungen im Fokus: @mathiasjachs.bsky.social, #ResearcherOfTheMonth der #MedUniWien, hat gezeigt, dass Pfortaderhochdruck schmerzfrei durch Messung der Organsteifigkeit diagnostiziert werden kann.
Mehr im Video in gesamter Länge! 🎥➡️ https://bit.ly/3G6VoGC
Mehr im Video in gesamter Länge! 🎥➡️ https://bit.ly/3G6VoGC
REMEMBERING PROFESSOR JAUME BOSCH
President of Bavneo @bavenocoop.bsky.social
Friend and Mentor to many
President of Bavneo @bavenocoop.bsky.social
Friend and Mentor to many
July 17, 2025 at 8:36 AM
REMEMBERING PROFESSOR JAUME BOSCH
President of Bavneo @bavenocoop.bsky.social
Friend and Mentor to many
President of Bavneo @bavenocoop.bsky.social
Friend and Mentor to many
Reposted by Thomas Reiberger
🖤 With deep sorrow, we announce the passing of Prof. Dr. Jaime Bosch, President of the Baveno Cooperation.
A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.
Rest in peace, Jaime
A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.
Rest in peace, Jaime
July 16, 2025 at 7:11 AM
🖤 With deep sorrow, we announce the passing of Prof. Dr. Jaime Bosch, President of the Baveno Cooperation.
A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.
Rest in peace, Jaime
A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.
Rest in peace, Jaime
🎂 30Y of .mp3 🎵
created @ Frauenhofer Institute 🔗 t.ly/f6A1t
by 🧑🎓 Karlheinz Brandenburg 🔗 t.ly/8vojd
🙏 for good vibes when i grew up
♻️ Napster 🔗 t.ly/lqPRP
⏯️ Winamp 🔗 t.ly/_sR05
created @ Frauenhofer Institute 🔗 t.ly/f6A1t
by 🧑🎓 Karlheinz Brandenburg 🔗 t.ly/8vojd
🙏 for good vibes when i grew up
♻️ Napster 🔗 t.ly/lqPRP
⏯️ Winamp 🔗 t.ly/_sR05
July 14, 2025 at 9:01 AM
🎂 30Y of .mp3 🎵
created @ Frauenhofer Institute 🔗 t.ly/f6A1t
by 🧑🎓 Karlheinz Brandenburg 🔗 t.ly/8vojd
🙏 for good vibes when i grew up
♻️ Napster 🔗 t.ly/lqPRP
⏯️ Winamp 🔗 t.ly/_sR05
created @ Frauenhofer Institute 🔗 t.ly/f6A1t
by 🧑🎓 Karlheinz Brandenburg 🔗 t.ly/8vojd
🙏 for good vibes when i grew up
♻️ Napster 🔗 t.ly/lqPRP
⏯️ Winamp 🔗 t.ly/_sR05
Drs. @LorenzBALCAR of @meduniwien.ac.at & @MartaTONON identify a #cirrhosis population with #ascites at particular risk for shortterm #PortalHypertension complications
@jhepatology.bsky.social Reports: t.ly/iCvXY
Ascites #Grade3 + 🚨 MELD ≥12 or 🚨 Na ≤135
➡️ good candidates for #TIPS
@jhepatology.bsky.social Reports: t.ly/iCvXY
Ascites #Grade3 + 🚨 MELD ≥12 or 🚨 Na ≤135
➡️ good candidates for #TIPS
Risk of portal hypertensive complications preventable by TIPS in patients with ascites
Transjugular intrahepatic portosystemic shunt (TIPS) is an effective treatment of
recurrent/refractory ascites in patients with cirrhosis. The aim of this study was
to identify patients with ascites a...
t.ly
July 8, 2025 at 5:52 AM
Drs. @LorenzBALCAR of @meduniwien.ac.at & @MartaTONON identify a #cirrhosis population with #ascites at particular risk for shortterm #PortalHypertension complications
@jhepatology.bsky.social Reports: t.ly/iCvXY
Ascites #Grade3 + 🚨 MELD ≥12 or 🚨 Na ≤135
➡️ good candidates for #TIPS
@jhepatology.bsky.social Reports: t.ly/iCvXY
Ascites #Grade3 + 🚨 MELD ≥12 or 🚨 Na ≤135
➡️ good candidates for #TIPS
Drs. @LukasHARTL and @MarleneHINTERSTEININGER of @meduniwien.ac.at showed in @CGH @AGA that
adding the #Vasopressin #ADH Biomarker #Copeptin to the MELD score improves prognostication of patients with #cirrhosis #ACLD
📖 the full study 🔗 t.ly/11GOg
@easlnews.bsky.social @bavenocoop.bsky.social
adding the #Vasopressin #ADH Biomarker #Copeptin to the MELD score improves prognostication of patients with #cirrhosis #ACLD
📖 the full study 🔗 t.ly/11GOg
@easlnews.bsky.social @bavenocoop.bsky.social
July 6, 2025 at 8:05 AM
Drs. @LukasHARTL and @MarleneHINTERSTEININGER of @meduniwien.ac.at showed in @CGH @AGA that
adding the #Vasopressin #ADH Biomarker #Copeptin to the MELD score improves prognostication of patients with #cirrhosis #ACLD
📖 the full study 🔗 t.ly/11GOg
@easlnews.bsky.social @bavenocoop.bsky.social
adding the #Vasopressin #ADH Biomarker #Copeptin to the MELD score improves prognostication of patients with #cirrhosis #ACLD
📖 the full study 🔗 t.ly/11GOg
@easlnews.bsky.social @bavenocoop.bsky.social
Reposted by Thomas Reiberger
🌍⏩ #MedUniVienna ranks 66th in #ClinicalMedicine and is among the top 200 in the US News Global #UniversityRanking.
🔝📌 In the @timeshighered.bsky.social Impact Ranking 2025, MedUni Vienna is 10th worldwide in "Good Health and Well-Being".
Details ⬇️
🔝📌 In the @timeshighered.bsky.social Impact Ranking 2025, MedUni Vienna is 10th worldwide in "Good Health and Well-Being".
Details ⬇️
US News Ranking: MedUni Vienna among the best medical universities in the world
Read more!
www.meduniwien.ac.at
June 18, 2025 at 12:11 PM
🌍⏩ #MedUniVienna ranks 66th in #ClinicalMedicine and is among the top 200 in the US News Global #UniversityRanking.
🔝📌 In the @timeshighered.bsky.social Impact Ranking 2025, MedUni Vienna is 10th worldwide in "Good Health and Well-Being".
Details ⬇️
🔝📌 In the @timeshighered.bsky.social Impact Ranking 2025, MedUni Vienna is 10th worldwide in "Good Health and Well-Being".
Details ⬇️
The #HEPEX Hepatic Experimental Lab at @meduniwien.ac.at and @cemm.oeaw.ac.at works on Disease-driving #Pathomechanisms in #Liver #Fibrosis & #PortalHypertension
🕸️ #Macrophages in #Fibrosis Resolution
🤖 #MachineLearning & #Pathomics in #LiverHistology
🦠 #Gut-Liver-Axis
🩸 #Anticoagulation
🕸️ #Macrophages in #Fibrosis Resolution
🤖 #MachineLearning & #Pathomics in #LiverHistology
🦠 #Gut-Liver-Axis
🩸 #Anticoagulation
June 19, 2025 at 1:59 PM
The #HEPEX Hepatic Experimental Lab at @meduniwien.ac.at and @cemm.oeaw.ac.at works on Disease-driving #Pathomechanisms in #Liver #Fibrosis & #PortalHypertension
🕸️ #Macrophages in #Fibrosis Resolution
🤖 #MachineLearning & #Pathomics in #LiverHistology
🦠 #Gut-Liver-Axis
🩸 #Anticoagulation
🕸️ #Macrophages in #Fibrosis Resolution
🤖 #MachineLearning & #Pathomics in #LiverHistology
🦠 #Gut-Liver-Axis
🩸 #Anticoagulation
@who.int has set Elimination of
🦠 #ViralHepatitis #B #C as a global goal for 2030
#Prisons remain a Hot ♨️ Spot for #HepC #HCV
In Vienna 🇦🇹 we focus on the incarcerated risk population
and offer onsite screening and treatment
@worldhepalliance.bsky.social
@easlnews.bsky.social
🦠 #ViralHepatitis #B #C as a global goal for 2030
#Prisons remain a Hot ♨️ Spot for #HepC #HCV
In Vienna 🇦🇹 we focus on the incarcerated risk population
and offer onsite screening and treatment
@worldhepalliance.bsky.social
@easlnews.bsky.social
June 17, 2025 at 11:36 AM
@who.int has set Elimination of
🦠 #ViralHepatitis #B #C as a global goal for 2030
#Prisons remain a Hot ♨️ Spot for #HepC #HCV
In Vienna 🇦🇹 we focus on the incarcerated risk population
and offer onsite screening and treatment
@worldhepalliance.bsky.social
@easlnews.bsky.social
🦠 #ViralHepatitis #B #C as a global goal for 2030
#Prisons remain a Hot ♨️ Spot for #HepC #HCV
In Vienna 🇦🇹 we focus on the incarcerated risk population
and offer onsite screening and treatment
@worldhepalliance.bsky.social
@easlnews.bsky.social
Reposted by Thomas Reiberger
We kicked off the week with Roger Kamm (@mitdeptofbe.bsky.social) for a #CeMMinar on brain neurovascular models & its applications to modeling drug & toxin transport. Thanks to Roger for the great insights & hosts @lderooij.bsky.social & @ar-abdelfattah.bsky.social
June 16, 2025 at 1:38 PM
We kicked off the week with Roger Kamm (@mitdeptofbe.bsky.social) for a #CeMMinar on brain neurovascular models & its applications to modeling drug & toxin transport. Thanks to Roger for the great insights & hosts @lderooij.bsky.social & @ar-abdelfattah.bsky.social
🇦🇹 Austrian GI/Liver Meeting 2025
3 rising 🌟 stars of our research group #MOTION
@crgmotion.bsky.social @meduniwien.ac.at presented
posters on hot 🔥 topics in #Hepatology
- Clinical Course of #NAD non-acute decompensation
- #SpleenStiffness in #PortalHypertension
- #Ultrasound Elastography in MASLD
3 rising 🌟 stars of our research group #MOTION
@crgmotion.bsky.social @meduniwien.ac.at presented
posters on hot 🔥 topics in #Hepatology
- Clinical Course of #NAD non-acute decompensation
- #SpleenStiffness in #PortalHypertension
- #Ultrasound Elastography in MASLD
June 15, 2025 at 7:53 PM
🇦🇹 Austrian GI/Liver Meeting 2025
3 rising 🌟 stars of our research group #MOTION
@crgmotion.bsky.social @meduniwien.ac.at presented
posters on hot 🔥 topics in #Hepatology
- Clinical Course of #NAD non-acute decompensation
- #SpleenStiffness in #PortalHypertension
- #Ultrasound Elastography in MASLD
3 rising 🌟 stars of our research group #MOTION
@crgmotion.bsky.social @meduniwien.ac.at presented
posters on hot 🔥 topics in #Hepatology
- Clinical Course of #NAD non-acute decompensation
- #SpleenStiffness in #PortalHypertension
- #Ultrasound Elastography in MASLD
Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decades - Gastrointestinal Endoscopy www.giejournal.org/article/S001...
Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decades
Acute variceal bleeding (AVB), a severe adverse event of portal hypertension, may
cause death in patients with cirrhosis. We investigated whether outcomes after AVB
have improved over time.
www.giejournal.org
June 12, 2025 at 9:15 PM
Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decades - Gastrointestinal Endoscopy www.giejournal.org/article/S001...
📈 Activation of🩸#Vasopressin System in #Cirrhosis tries to compensate for 🫀 #hemodynamic & 💧#sodium #fluid abnormalities
Drs. HARTL & HINTERSTEININGER of @meduniwien.ac.at
in 🤝with efclif.com show in📕 #CGH
🔗 t.ly/joCs5
▶️ #Vasopressin biomarker #COPEPTIN predicts #ACLF in cirrhosis
Drs. HARTL & HINTERSTEININGER of @meduniwien.ac.at
in 🤝with efclif.com show in📕 #CGH
🔗 t.ly/joCs5
▶️ #Vasopressin biomarker #COPEPTIN predicts #ACLF in cirrhosis
June 6, 2025 at 7:40 AM
📈 Activation of🩸#Vasopressin System in #Cirrhosis tries to compensate for 🫀 #hemodynamic & 💧#sodium #fluid abnormalities
Drs. HARTL & HINTERSTEININGER of @meduniwien.ac.at
in 🤝with efclif.com show in📕 #CGH
🔗 t.ly/joCs5
▶️ #Vasopressin biomarker #COPEPTIN predicts #ACLF in cirrhosis
Drs. HARTL & HINTERSTEININGER of @meduniwien.ac.at
in 🤝with efclif.com show in📕 #CGH
🔗 t.ly/joCs5
▶️ #Vasopressin biomarker #COPEPTIN predicts #ACLF in cirrhosis
#LiverResearch team #HEPEX-Lab @meduniwien.ac.at is affiliated w Center for Molecular Medicine @cemm.oeaw.ac.at
@KatjaSommer #Gut-Liver-Axis
@VladTaru #LiverFailure #ACLF
@BenHofer #Cirrhosis #Recompensation
@KathiBonitz restaurative #Macrophages
@ThomasSorz #AI Patho Spatial Transcritomics
@KatjaSommer #Gut-Liver-Axis
@VladTaru #LiverFailure #ACLF
@BenHofer #Cirrhosis #Recompensation
@KathiBonitz restaurative #Macrophages
@ThomasSorz #AI Patho Spatial Transcritomics
🔬 New #EquationsForLife! @reibergerthomas.bsky.social's Group studies #PortalHypertension & uses #OhmsLaw to model blood flow. Their 2024 studies reveal gene expression patterns linked to PH & show it is a key risk factor for complicatoins in #MASLD.
🔎 tinyurl.com/CeMMRR2024-R...
🔎 tinyurl.com/CeMMRR2024-R...
June 4, 2025 at 10:51 AM
#LiverResearch team #HEPEX-Lab @meduniwien.ac.at is affiliated w Center for Molecular Medicine @cemm.oeaw.ac.at
@KatjaSommer #Gut-Liver-Axis
@VladTaru #LiverFailure #ACLF
@BenHofer #Cirrhosis #Recompensation
@KathiBonitz restaurative #Macrophages
@ThomasSorz #AI Patho Spatial Transcritomics
@KatjaSommer #Gut-Liver-Axis
@VladTaru #LiverFailure #ACLF
@BenHofer #Cirrhosis #Recompensation
@KathiBonitz restaurative #Macrophages
@ThomasSorz #AI Patho Spatial Transcritomics
Study by our #Liver #Team @meduniwien.ac.at
and @MedHochschuleHannover
Minimal residual ascites 3 months after #TIPS implantation implicates worse clinical outcome in patients with #liver #cirrhosis
published in @jhepatology.bsky.social #Reports
🔗 sciencedirect.com/science/arti...
and @MedHochschuleHannover
Minimal residual ascites 3 months after #TIPS implantation implicates worse clinical outcome in patients with #liver #cirrhosis
published in @jhepatology.bsky.social #Reports
🔗 sciencedirect.com/science/arti...
Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosis
Transjugular intrahepatic portosystemic shunt (TIPS) implantation is indicated for recurrent/refractory ascites in patients with cirrhosis. The progno…
sciencedirect.com
June 4, 2025 at 6:12 AM
Study by our #Liver #Team @meduniwien.ac.at
and @MedHochschuleHannover
Minimal residual ascites 3 months after #TIPS implantation implicates worse clinical outcome in patients with #liver #cirrhosis
published in @jhepatology.bsky.social #Reports
🔗 sciencedirect.com/science/arti...
and @MedHochschuleHannover
Minimal residual ascites 3 months after #TIPS implantation implicates worse clinical outcome in patients with #liver #cirrhosis
published in @jhepatology.bsky.social #Reports
🔗 sciencedirect.com/science/arti...
#LiverSky
📘 JOURNAL OF HEPATOLOGY #JHEPATOL
@jhepatology.bsky.social
is the flagshipjournal of 🇪🇺 #EASL @easlnews.bsky.social
📈 Impact Factor of 26.8 ➡️ 2.1% 🔝Percentile
Consider to submit your #Liver #Research
🔗 www.journal-of-hepatology.eu
@heinerwedemeyer.bsky.social
@docberza.bsky.social
📘 JOURNAL OF HEPATOLOGY #JHEPATOL
@jhepatology.bsky.social
is the flagshipjournal of 🇪🇺 #EASL @easlnews.bsky.social
📈 Impact Factor of 26.8 ➡️ 2.1% 🔝Percentile
Consider to submit your #Liver #Research
🔗 www.journal-of-hepatology.eu
@heinerwedemeyer.bsky.social
@docberza.bsky.social
June 3, 2025 at 9:19 AM
#LiverSky
📘 JOURNAL OF HEPATOLOGY #JHEPATOL
@jhepatology.bsky.social
is the flagshipjournal of 🇪🇺 #EASL @easlnews.bsky.social
📈 Impact Factor of 26.8 ➡️ 2.1% 🔝Percentile
Consider to submit your #Liver #Research
🔗 www.journal-of-hepatology.eu
@heinerwedemeyer.bsky.social
@docberza.bsky.social
📘 JOURNAL OF HEPATOLOGY #JHEPATOL
@jhepatology.bsky.social
is the flagshipjournal of 🇪🇺 #EASL @easlnews.bsky.social
📈 Impact Factor of 26.8 ➡️ 2.1% 🔝Percentile
Consider to submit your #Liver #Research
🔗 www.journal-of-hepatology.eu
@heinerwedemeyer.bsky.social
@docberza.bsky.social